260 related articles for article (PubMed ID: 27188273)
1. Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.
Alberts CJ; Vos RA; Borgdorff H; Vermeulen W; van Bergen J; Bruisten SM; Geerlings SE; Snijder MB; van Houdt R; Morré SA; de Vries HJ; van de Wijgert JH; Prins M; Schim van der Loeff MF
Sex Transm Infect; 2016 Dec; 92(8):611-618. PubMed ID: 27188273
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus seroprevalence in men and women of six different ethnicities in Amsterdam, the Netherlands: The HELIUS study.
Alberts CJ; Michel A; Bruisten S; Snijder MB; Prins M; Waterboer T; Schim van der Loeff MF
Papillomavirus Res; 2017 Jun; 3():57-65. PubMed ID: 28720457
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands - the HELIUS study.
Kovaleva A; Alberts CJ; Waterboer T; Michel A; Snijder MB; Vermeulen W; Coyer L; Prins M; Schim van der Loeff M
BMC Infect Dis; 2016 Sep; 16(1):502. PubMed ID: 27659061
[TBL] [Abstract][Full Text] [Related]
4. Vaginal and anal human papillomavirus infection and seropositivity among female sex workers in Amsterdam, the Netherlands: Prevalence, concordance and risk factors.
Marra E; Kroone N; Freriks E; van Dam CL; Alberts CJ; Hogewoning AA; Bruisten S; van Dijk A; Kroone MM; Waterboer T; Schim van der Loeff MF
J Infect; 2018 Apr; 76(4):393-405. PubMed ID: 29289562
[TBL] [Abstract][Full Text] [Related]
5. Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) study.
Hulstein SH; Matser A; Alberts CJ; Snijder MB; Willhauck-Fleckenstein M; Hufnagel K; Prins M; de Vries HJC; Schim van der Loeff MF; Waterboer T
BMC Infect Dis; 2018 Dec; 18(1):612. PubMed ID: 30509189
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
Tay SK; Oon LL
Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
[TBL] [Abstract][Full Text] [Related]
7. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH
Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.
Agorastos T; Chatzistamatiou K; Zafrakas M; Siamanta V; Katsamagkas T; Constantinidis TC; Lampropoulos AF;
Eur J Cancer Prev; 2014 Sep; 23(5):425-31. PubMed ID: 24977385
[TBL] [Abstract][Full Text] [Related]
9. Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
Woestenberg PJ; King AJ; van Benthem BHB; Donken R; Leussink S; van der Klis FRM; de Melker HE; van der Sande MAB; Hoebe CJPA; Bogaards JA;
J Infect Dis; 2018 Jan; 217(2):213-222. PubMed ID: 29140439
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
12. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
13. Ethnic Disparities in CKD in the Netherlands: The Healthy Life in an Urban Setting (HELIUS) Study.
Agyemang C; Snijder MB; Adjei DN; van den Born BJ; Modesti PA; Peters RJ; Stronks K; Vogt L
Am J Kidney Dis; 2016 Mar; 67(3):391-9. PubMed ID: 26342454
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Neovaginal High-Risk Human Papillomavirus Among Transgender Women in The Netherlands.
van der Sluis WB; Buncamper ME; Bouman MB; Elfering L; Özer M; Bogaarts M; Steenbergen RD; Heideman DA; Mullender MG
Sex Transm Dis; 2016 Aug; 43(8):503-5. PubMed ID: 27414682
[TBL] [Abstract][Full Text] [Related]
15. Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.
Fu TC; Carter JJ; Hughes JP; Feng Q; Hawes SE; Schwartz SM; Xi LF; Lasof T; Stern JE; Galloway DA; Koutsky LA; Winer RL
Int J Cancer; 2016 Nov; 139(10):2201-12. PubMed ID: 27448488
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.
Mollers M; Scherpenisse M; van der Klis FR; King AJ; van Rossum TG; van Logchem EM; Feltkamp MC; Meijer CJ; Snijders PJ; Boot HJ; de Melker HE
Cancer Epidemiol; 2012 Dec; 36(6):519-24. PubMed ID: 22906483
[TBL] [Abstract][Full Text] [Related]
18. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population.
Khoo SP; Bhoo-Pathy N; Yap SH; Anwar Shafii MK; Hairizan Nasir N; Belinson J; Subramaniam S; Goh PP; Zeng M; Tan HD; Gravitt P; Woo YL
Sex Transm Infect; 2018 Jun; 94(4):277-283. PubMed ID: 29180538
[TBL] [Abstract][Full Text] [Related]
20. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands.
Borgdorff H; van der Veer C; van Houdt R; Alberts CJ; de Vries HJ; Bruisten SM; Snijder MB; Prins M; Geerlings SE; Schim van der Loeff MF; van de Wijgert JHHM
PLoS One; 2017; 12(7):e0181135. PubMed ID: 28700747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
